Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Editorial introductions

Editorial introductions URRENT PINION Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into nine sections that are reviewed once a year. Each section is assigned one or two Section Editors, leading authorities in the area, who identify the most important topics at that time. Here we are pleased to introduce the Journal’s Section Editors for this issue. SECTION EDITORS Through research, clinical care, and mentoring activ- ities, she brings a cross-disciplinary approach to clin- Virginia A. Triant ical outcomes research with the goal of improving long term outcomes and enhancing the care and well- being of vulnerable populations. Dr Triant is a clinician and clinical investigator in the Infectious Dis- eases and General Internal Medi- Matthieu Perreau cine Divisions at Massachusetts General Hospital (MGH) USA, dedicated to studying the long- Matthieu Perreau is Associate term non-communicable disease Professor at the Service of Immu- and aging-related complications nology and Allergy, Lausanne of HIV infection. The focus of Dr University Hospital, Lausanne, Triant’s research has been on the Switzerland. After receiving his intersection between HIV and cardiovascular disease PhD from Montpellier University, and non-communicable chronic disease complica- France, he subsequentlyjoined the tions. She has investigated rates and determinants Service of Immunology and of clinical outcomes such as myocardial infarction, Allergy, Lausanne University Hos- stroke, and fracture in HIV, and is currently inves- pital, focusingontheevaluationof tigating optimal cardiovascular risk prediction strat- HIV-1 vaccine immunogenicity and on the delinea- egies in HIV and HIV/HCV co-infected individuals. tion of HIV-1 immunopathogenesis. More recently, Dr Triant is an active infectious diseases clinician, he focused on the identification of immunological and virological parameters contributing to HIV per- maintaining an outpatient clinic and attending on sistence. the infectious diseases consult service at MGH. 1746-630X Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved. www.co-hivandaids.com Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in HIV and AIDS Wolters Kluwer Health

Editorial introductions

Download PDF
1 page

Loading next page...
 
/lp/wolters-kluwer-health/editorial-introductions-Hf4GTZYoRd

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
1746-630X
eISSN
1746-6318
DOI
10.1097/coh.0000000000000758
Publisher site
See Article on Publisher Site

Abstract

URRENT PINION Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into nine sections that are reviewed once a year. Each section is assigned one or two Section Editors, leading authorities in the area, who identify the most important topics at that time. Here we are pleased to introduce the Journal’s Section Editors for this issue. SECTION EDITORS Through research, clinical care, and mentoring activ- ities, she brings a cross-disciplinary approach to clin- Virginia A. Triant ical outcomes research with the goal of improving long term outcomes and enhancing the care and well- being of vulnerable populations. Dr Triant is a clinician and clinical investigator in the Infectious Dis- eases and General Internal Medi- Matthieu Perreau cine Divisions at Massachusetts General Hospital (MGH) USA, dedicated to studying the long- Matthieu Perreau is Associate term non-communicable disease Professor at the Service of Immu- and aging-related complications nology and Allergy, Lausanne of HIV infection. The focus of Dr University Hospital, Lausanne, Triant’s research has been on the Switzerland. After receiving his intersection between HIV and cardiovascular disease PhD from Montpellier University, and non-communicable chronic disease complica- France, he subsequentlyjoined the tions. She has investigated rates and determinants Service of Immunology and of clinical outcomes such as myocardial infarction, Allergy, Lausanne University Hos- stroke, and fracture in HIV, and is currently inves- pital, focusingontheevaluationof tigating optimal cardiovascular risk prediction strat- HIV-1 vaccine immunogenicity and on the delinea- egies in HIV and HIV/HCV co-infected individuals. tion of HIV-1 immunopathogenesis. More recently, Dr Triant is an active infectious diseases clinician, he focused on the identification of immunological and virological parameters contributing to HIV per- maintaining an outpatient clinic and attending on sistence. the infectious diseases consult service at MGH. 1746-630X Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved. www.co-hivandaids.com Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Journal

Current Opinion in HIV and AIDS – Wolters Kluwer Health

Published: Sep 1, 2022

There are no references for this article.